Literature DB >> 6790020

Maternal methyldopa treatment and neonatal blood pressure.

A Whitelaw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790020      PMCID: PMC1506236          DOI: 10.1136/bmj.283.6289.471

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Plasma renin and blood pressure during treatment with methyldopa.

Authors:  P Weidmann; D Hirsch; M H Maxwell; R Okun; P Schroth
Journal:  Am J Cardiol       Date:  1974-11       Impact factor: 2.778

2.  Fetal outcome in trial of antihypertensive treatment in pregnancy.

Authors:  C W Redman
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

3.  Evaluating indirect blood pressure measurement techniques: a comparison of three systems in infants and children.

Authors:  R F Reder; I Dimich; M L Cohen; L Steinfeld
Journal:  Pediatrics       Date:  1978-09       Impact factor: 7.124

4.  A study of the disposition of alpha-methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy.

Authors:  H M Jones; A J Cummings; K D Setchell; A M Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

  4 in total
  6 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 2.  The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

Authors:  C Knott
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 3.  Determinants of neonatal blood pressure.

Authors:  Alison L Kent; Tejasvi Chaudhari
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

4.  Vasoactivity of the major intracranial arteries in newborn infants.

Authors:  M R Drayton; R Skidmore
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

5.  Treatment of cardiovascular diseases.

Authors:  K R Lees; P C Rubin
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

Review 6.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.